HolidayUnder100 Helps Plan Best Value Holidays for Residents Across the UK

HolidayUnder100 is changing the face of vacations and holiday packages by planning short-term and long-term breaks on a budget of £100 or less!

HolidayUnder100 provides the most affordable, cheap holidays in the UK and around Europe.”

— HolidayUnder100

CHAPELTON, DEVON, UNITED KINGDOM, December 31, 2022 /EINPresswire.com/ -- Amidst busy schedules and the widespread 9-5 job setup, a quick getaway can help harmonize the work-life balance. Working around the clock has been normalized a little too much during and post-pandemic, especially in work-from-home scenarios. Sometimes, people invest so

GAMECHANGERS Country Awards 2022 awarded Lucas Blantford the UK Rising Talent of the Year (Sport & Entertainment)

GAMECHANGERS Country Awards 2022 awarded Lucas Blantford the UK Rising Talent of the Year (Sport & Entertainment)

LONDON, UNITED KINGDOM, December 24, 2022 /EINPresswire.com/ -- Mr. Adrian Blantford, Principal Manager, Lucas Blantford Racing Team, announced today that the UK's largest and most prestigious awards program presented by Gamechangers

Superyachters Launches Online Community and Streaming Service for Luxury Yacht Industry

Founder of Superyachters

Logo for Superyachters

Superyacht

New platform offers yacht enthusiasts a unique opportunity to connect, collaborate, and find professionals in the industry

We are thrilled to launch Superyachters and provide a new platform for yacht enthusiasts to connect and share their passion for luxury yachts”

— Douglas McFarlane

RICHMOND, LONDON, UK, December 20, 2022 /EINPresswire.com/ -- London, United Kingdom Dec 20, 2022 (Issuewire.com) - Superyachters Launches Online Community and Streaming Service for Luxury Yacht Industry

The new platform offers yacht

Intellomx Receives Coveted Approval in China for its Novel Diagnostic Study on Detection of Latent Luberculosis

Intellomx Corporate Logo

Xianxiang Chen, Chairman of Wuhan Pulmonary Hospital

Photo of Simon Haworth, Director of Intellomx

Intellomx have received Chinese government approval for a novel clinical diagnostics study for TB, to distinguish patients with latent TB using biomarkers.

We believe that our collaboration on a novel approach for detection of latent tuberculosis will herald a new beginning for TB treatment and prevention as well as for our important Sino-UK partnership.”

— Xianxiang Chen

NOTTINGHAM, UK, December 20, 2022 /EINPresswire.com/ -- The Ministry of Science & Technology (MOST) in Beijing announced this week that UK drug-discovery AI company Intelligent OMICS has